Search

everythinglearnresearchcommunity

for

Search:↓

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Long-term etretinate use may cause delayed wound healing and extra tissue growth after injury.

New method accurately measures finasteride and M3 in urine, helping evaluate pharmacokinetics.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

Umbilical cord-derived media is safe and effective for hair growth.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

A woman's mature cystic teratoma caused her virilization by producing testosterone.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Some treatments work better for different types of hair loss, and nutrients like iron and L-lysine are important for preventing hair loss.

The document concludes that individualized treatments for hair issues are effective, certain hair changes can indicate neurocutaneous diseases, specific lotions improve skin health, laser hair removal works but needs more study on long-term effects, men's cosmetics are diverse, peeling is effective but can have side effects, and facial pigmentation is often due to overactive skin cells.

Hair changes could indicate neurological diseases and help monitor treatment.

Treatments for hair loss vary, but cell-based options may be the future.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Flutamide may slightly improve hair loss in women, but finasteride does not work.